This inventor holds 1 USPTO granted patent. Top assignee: Shenzhen People's Hospital. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations in Colorectal Cancer Prognostics: The Work of Jiaxin Cheng
Introduction:
Jiaxin Cheng, an inventive mind hailing from Shenzhen, China, has made significant advancements in the field of medical technology. With a focus on improving the evaluation of collagen in diagnostic processes, his contributions hold great promise for the early detection and prognostication of colorectal cancer.
Latest Patents:
Cheng is the sole inventor of a groundbreaking patent titled "Apparatus for collagen evaluation and prognostic prediction of colorectal cancer and storage medium." This sophisticated system utilizes a computer-readable storage medium that, when executed by a processor, performs multi-photon imaging on histopathological sections rich with tumor environment information. The patent details the intricate image processing of tumor microenvironments, enabling the extraction of valuable collagen feature parameters. These include morphological, energy, and texture feature parameters from tumor tissue, invasive margins, and normal tissue regions. This innovative approach allows for a comprehensive analysis of inter-region differences and variations, leading to the establishment of a collagen feature scoring model essential for cancer prognosis.
Career Highlights:
Jiaxin Cheng is affiliated with Shenzhen People's Hospital, where he leverages his expertise to further medical innovations. His commitment to research and development in the medical field highlights his role as a leader in the fight against cancer diagnosis and management.
Collaborations:
Within his professional journey, Cheng has collaborated with esteemed colleagues, including Jun Yan and Shumin Dong. Together, they contribute to advancements in medical imaging and cancer treatment protocols, showcasing the power of teamwork in research initiatives.
Conclusion:
Jiaxin Cheng's innovation in colorectal cancer prognostics through technology represents a notable advancement in medical diagnostics. His patent not only underscores his ingenuity as an inventor but also emphasizes the importance of continued research and collaboration in the medical field to improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile